Navigation Links
Pilot Study to Test Effect of Mobile Phone Transmissions On Skin To Begin In Finland

HELSINKI - The radiation watchdog in Finland has decided to test the effects of radiation released from of mobile phones on human proteins by testing them directly on human skin in order to determine if these transmissions are detrimental to human health.//

A pilot study that is scheduled to begin sometime next week will expose a small area of skin on the participants' arms to cell phone radiation for about 60 minutes or the duration of a longish phone call. Research professor Dariusz Leszczynski confirmed that a skin sample will then be collected for further studies. In previous tests, researchers had found that cell phone transmissions cause shrinkage in cells, "Cells function in a different way when they are in the body than in laboratory surroundings. Now we want to confirm whether radiation causes cell level changes in humans as well," Leszczynski said. His team hopes to have the results of this study out by the end of the year and hope to solve the riddle of the effect of mobile phone transmissions on health of individuals. Some researchers speculate that the increase in the incidence of brain tumors has come about due to the increase in the usage of cell phones. "If harmful proteins get through to the brain, it could have an indirect link with cancer, but this is pure speculation,” Leszczynski stressed. Finland is the home country of Nokia, the world's largest mobile phone manufacturer and almost everyone owns a handset here.

Page: 1

Related medicine news :

1. Airlines Pilot At Heightened Risk Of Having Cataracts
2. Pilot Study Proves Home Abortions ‘Safe’
3. Villagers in Tamil Nadu Take Part in Diabetes Pilot Project
4. School of Medicine, GE Introduce Ultrasound Pilot Study
5. Spinal Cord Stimulation Pilot Study for Chronic Angina
6. Pilot Crashes Himself, Daughter, into House
7. Tomato Sauce reduces Cancer Risk- Study
8. Study on obesity and heart failure
9. National Lung Study in the process
10. Study casts doubt on keyboard ills
11. Study reveals how stress can make you sick
Post Your Comments:

(Date:12/1/2015)... ... 2015 , ... Dr. Paul Vitenas, one of the top cosmetic surgeons ... magazine as the Best Single Physician Practice in the nation. Dr. Vitenas and his ... honored by the industry publication. , Dr. Vitenas said he was very honored ...
(Date:12/1/2015)... ... December 01, 2015 , ... Speech and ... believe that with innovative technologies and under the right circumstances, these practices can ... benefit of a dual-approach to his or her therapeutic sessions, as well as ...
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... continue the expansion of the company’s growing product line of food safety and ... tshawytscha) and Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the start ... scientific research and discoveries, leading us to better understand the disease’s behavior. Globally, ... affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight on ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation ... company specializing in oncology, today announced that it has ... company,s pivotal global Phase 3 clinical trial of aldoxorubicin ... was originally estimated to be completed in Q1 2016. The ... conducted under a Special Protocol Assessment from the FDA ...
Breaking Medicine Technology: